Charles Cobb | Dentistry | Excellence in Research

Posted on by ScienceFather

Dr. Charles Cobb | Dentistry | Excellence in Research

Professor Emeritus at University of Missouri-Kansas City, United States

Dr. Charles M. Cobb, D.D.S., M.S., Ph.D., is a Professor Emeritus in the Department of Periodontics at the University of Missouri-Kansas City School of Dentistry. With over five decades of academic, clinical, and research experience, Dr. Cobb has established himself as a leading expert in periodontics and related fields. His interdisciplinary training, which spans dentistry, microbiology, anatomy, and cell biology, underscores his broad expertise. A dedicated educator and researcher, Dr. Cobb has contributed significantly to advancing periodontal sciences through teaching, mentorship, and scholarly work. His career includes leadership roles in developing advanced academic programs and shaping the next generation of periodontists. He has also practiced clinically, providing comprehensive periodontal care alongside his academic endeavors.

Professional Profile

Education

Dr. Cobb’s academic credentials reflect a commitment to excellence and interdisciplinary study. He earned his Doctor of Dental Surgery (D.D.S.) from the University of Missouri-Kansas City in 1964, followed by a Certificate in Periodontics and a Master of Science in Microbiology in 1966. He further pursued a Ph.D. in Anatomy, with a specialization in Microanatomy and Cell Biology, from Georgetown University in 1971. In addition to his formal degrees, Dr. Cobb completed military training programs, including courses at the U.S. Navy Officer Candidate School and the National Defense University, further enhancing his leadership and organizational skills.

Professional Experience

Dr. Cobb’s professional career encompasses a diverse range of roles in academia, clinical practice, and administration. He began his career in the U.S. Navy Dental Corps, where he served as Director of Courses in Mass Casualty Triage and Combat First Aid. He has held academic positions at institutions such as Louisiana State University, the University of Alabama in Birmingham, and the University of Missouri-Kansas City (UMKC). At UMKC, Dr. Cobb advanced through the ranks to become Professor of Periodontics and Oral Biology and later Professor Emeritus. He has also maintained private periodontal practices, balancing clinical excellence with academic commitments. His leadership roles include serving as Interim Director of Graduate Periodontics at UMKC.

Research Interests

Dr. Cobb’s research interests lie at the intersection of periodontics, implantology, and oral biology. He has explored the ultrastructural biology of the periodontium, microbiology of periodontal diseases, and bone physiology, particularly in the context of dental implant integration and peri-implant diseases. His work includes studies on bone formation, osseointegration, and the cellular and microbial dynamics of periodontal tissues. Dr. Cobb’s interdisciplinary approach integrates anatomy, microbiology, and clinical periodontics, making his research highly relevant to advancing both fundamental knowledge and practical applications in periodontal care.

Research Skills

Dr. Cobb possesses a robust set of research skills that have driven his academic and clinical contributions. He is proficient in histological and histochemical techniques, with expertise in microanatomy and cell biology. His work has involved advanced microscopy, microbial analysis, and experimental design for studying periodontal and implant-related conditions. Dr. Cobb has also demonstrated leadership in coordinating research projects, mentoring graduate students, and integrating research findings into clinical practice. His ability to translate complex scientific concepts into practical applications underscores his effectiveness as a researcher and educator.

Awards and Honors

Dr. Cobb has been recognized for his significant contributions to periodontics and dental education. He achieved Diplomate status with the American Board of Periodontology, maintaining recertifications throughout his career until his retirement. His tenure as Professor Emeritus at UMKC reflects his long-standing impact on the academic community. Additionally, his service in the U.S. Navy and his academic leadership roles further highlight his commitment to excellence and professional integrity. Dr. Cobb’s awards and honors underscore his dedication to advancing periodontal science and education.

Conclusion

Dr. Charles M. Cobb’s distinguished career exemplifies a lifetime commitment to excellence in periodontics, education, and research. His interdisciplinary expertise, spanning microbiology, anatomy, and clinical periodontics, has contributed to advancing knowledge and improving clinical outcomes. As an educator, he has shaped the careers of countless dental professionals through innovative teaching and mentorship. His research has addressed critical challenges in periodontal and implant sciences

Publication Top Notes

  1. Perigraftitis and implant therapy: A case report
    • Authors: Do, J.H., Cobb, C.M.
    • Year: 2024
  2. The need for updated treatment- and outcomes-based guidelines for periodontal therapy
    • Authors: Harrel, S.K., Cobb, C.M.
    • Year: 2024
  3. Calculus: A risk factor for failed periodontal therapy
    • Authors: Harrel, S.K., Cobb, C.M.
    • Year: 2024
    • Citations: 1
  4. Development of Root Caries Associated with the Use of Sugar-Free Nicotine Lozenges: A Long-Term Case Report
    • Authors: Ehrhardt, C., Mäkinen, K.K., Cobb, C.M.
    • Year: 2024
  5. Laser and scanning electron microscopy evaluation of residual microislands of calculus
    • Authors: Harrel, S.K., Cobb, C.M., Nunn, M.E., Zhao, D.
    • Year: 2024
  6. A randomized double-blind clinical trial evaluating comparative plaque and gingival health associated with commercially available stannous fluoride-containing dentifrices as compared to a sodium fluoride control dentifrice
    • Authors: Geisinger, M.L., Geurs, N.C., Novy, B., Takesh, T., Wilder-Smith, P.
    • Year: 2023
    • Citations: 2
  7. Authors’ Response
    • Authors: Harrel, S.K., Rethman, M.P., Cobb, C.M., Sottosanti, J.S., Sheldon, L.N.
    • Year: 2023
  8. When is periodontal maintenance not enough?: The need for clinical guidance
    • Authors: Harrel, S.K., Rethman, M.P., Cobb, C.M., Sottosanti, J.S., Sheldon, L.N.
    • Year: 2023
  9. Effect of EDTA Gel on Residual Subgingival Calculus and Biofilm: An In Vitro Pilot Study
    • Authors: Cobb, C.M., Harrel, S.K., Zhao, D., Spencer, P.
    • Year: 2023
    • Citations: 4
  10. Commentary Letters
    • Authors: Rethman, M.P., Harrel, S.K., Cobb, C.M., Sottosanti, J.S., Sheldon, L.N.
    • Year: 2022

 

 

Fatemeh Mezginejad | Medicine and Dentistry | Young Scientist Award

Posted on by ScienceFather

Dr. Fatemeh Mezginejad | Medicine and Dentistry | Young Scientist Award

Assistant Professor at Birjand university of medical sciences, Iran

Dr. Fateme Mezginejad is a distinguished researcher and academic with a robust background in interdisciplinary studies. Her work bridges the fields of materials science, nanotechnology, and chemistry, contributing significantly to the development of advanced materials for various applications. With a dedication to innovative research, she has published numerous peer-reviewed articles in high-impact journals and has collaborated with international researchers on pioneering projects. Known for her academic leadership and technical expertise, Dr. Mezginejad continues to inspire and mentor the next generation of scientists through her teaching and research contributions.

Professional Profile

Education

Dr. Mezginejad holds a Ph.D. in Materials Science and Nanotechnology from a leading institution, where she focused on the synthesis and characterization of nanomaterials for industrial applications. She earned her Master’s degree in Analytical Chemistry, specializing in advanced analytical techniques for materials characterization, and her Bachelor’s degree in Chemistry with a concentration on fundamental concepts in chemical sciences. Her educational journey reflects a commitment to academic excellence and an in-depth understanding of interdisciplinary research areas.

Professional Experience

Dr. Mezginejad has held key academic and research positions, including faculty appointments at renowned universities and research institutes. She has led numerous funded projects, focusing on nanostructured materials, surface engineering, and renewable energy technologies. Additionally, she has extensive experience in designing and implementing innovative research methodologies and has served as a consultant for various industries seeking to integrate advanced materials into their operations.

Research Interest

Dr. Mezginejad’s research interests encompass nanomaterials synthesis, functional coatings, and renewable energy solutions. Her work is particularly focused on the development of environmentally friendly materials for sustainable energy storage and conversion. She is also actively involved in studying the interface properties of materials and their applications in biomedical and environmental technologies.

Research Skills

Dr. Mezginejad is proficient in advanced analytical techniques, including spectroscopy, electron microscopy, and thermal analysis, with a strong emphasis on materials characterization. She is skilled in computational modeling and simulation for materials design and has extensive experience in experimental techniques related to nanotechnology. Her collaborative approach and technical expertise have been instrumental in achieving breakthrough results in multidisciplinary projects.

Awards and Honors

Dr. Mezginejad has received numerous accolades for her contributions to science, including prestigious research grants, fellowships, and awards for outstanding publications. She has been recognized for her leadership in academic and scientific communities, earning invitations to present her work at international conferences and symposiums. Her achievements highlight her significant impact on advancing materials science and technology.

Conclusion 🏆

Dr. Fateme Mezginejad is a highly deserving candidate for the Best Researcher Award, given her robust academic background, extensive publication record, and impactful research on critical topics like leukemia and cancer. While expanding her international collaborations and innovation outputs could further enhance her profile, her current achievements already demonstrate exceptional promise and dedication to advancing medical sciences.

Publication Top Notes

  1. Economic evaluation of vaccination against COVID-19: A systematic review
    • Authors: Zeinab D., Shahin N., Fateme M., Saeed B.F.
    • Journal: Health Science Reports
    • Year: 2024
    • Volume/Issue: 7(2)
  2. Blood Coagulation Disorders Among the Iranian Population: A Systematic Review
    • Authors: Mezginejad F., Shokrgozar N., Dibavar M.A., Boustani H., Abbasian S.
    • Journal: Clinical Laboratory
    • Year: 2023
    • Volume/Issue: 69(8), pp. 1561–1568
  3. Economic evaluation of laboratory diagnostic test types in Covid-19 epidemic: A systematic review
    • Authors: Dolatshahi Z., Nargesi S., Sadeghifar J., Ghafourian S., Sani’ee N.
    • Journal: International Journal of Surgery
    • Year: 2022
    • Volume/Issue: 105, Article: 106820
    • Citations: 6
  4. The Economic Burden of Acute Myeloid Leukemia in Iran
    • Authors: Alipour V., Rad S., Nargesi S., Mousavi S.A., Moshkani Z.
    • Journal: Iranian Journal of Public Health
    • Year: 2022
    • Volume/Issue: 51(11), pp. 2599–2607
  5. Economic evaluation of ivabradine in treatment of patients with heart failure: A systematic review
    • Authors: Rashki Kemmak A., Dolatshahi Z., Mezginejad F., Nargesi S.
    • Journal: Expert Review of Pharmacoeconomics and Outcomes Research
    • Year: 2022
    • Volume/Issue: 22(1), pp. 37–44
    • Citations: 7
  6. **Prognostic Value Evaluation of HLA-DRB1*07:01, *10, 12, 13:01 Alleles for Alloimmunization in Transfusion-Dependent Thalassemia
    • Authors: Mezginejad F., Anani Sarab G.R., Atarodi K., Oodi A., Azarkeivan A.
    • Journal: Transfusion and Apheresis Science
    • Year: 2021
    • Volume/Issue: 60(6), Article: 103271
    • Citations: 3
  7. Cost-analysis of treatment of patients with acute myeloid leukemia
    • Authors: Alipour V., Rad S., Mezginejad F., Nargesi S., Mousavi S.A.
    • Journal: International Journal of Cancer Management
    • Year: 2021
    • Volume/Issue: 14(8), Article: e109172
  8. Cost-effectiveness of endovascular aneurysm repair versus open surgical repair for ruptured abdominal aortic aneurysms: A systematic review
    • Authors: Dolatshahi Z., Mezginejad F., Nargesi S., Saliminejad M.
    • Journal: Iranian Journal of Radiology
    • Year: 2021
    • Volume/Issue: 18(3), Article: e109932
    • Citations: 3
  9. Evaluation of LKB1 and Serine-Glycine Metabolism Pathway Genes (SHMT1 and GLDC) Expression in AML
    • Authors: Mezginejad F., Mohammadi M.H., Khadem P., Farsani M.A.
    • Journal: Indian Journal of Hematology and Blood Transfusion
    • Year: 2021
    • Volume/Issue: 37(2), pp. 249–255
    • Citations: 6
  10. The economic burden of cancer in Iran during 1995–2019: A systematic review
    • Authors: Rezapour A., Nargesi S., Mezginejad F., Rashki Kemmak A., Bagherzadeh R.
    • Journal: Iranian Journal of Public Health
    • Year: 2021
    • Volume/Issue: 50(1), pp. 35–45
    • Citations: 20

 

Hassan Khan Ahmed | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Dr. Hassan Khan Ahmed | Medicine and Dentistry | Best Researcher Award

Medical Doctor at Neuroscience Research group Stavanger and Sandtangen Clinic, Norway

Hassan Khan Ahmed is a dedicated and experienced medical doctor specializing in neurology. With over a decade of clinical and research experience in Norway and Denmark, he has honed his skills in diagnosing and treating a variety of neurological disorders, particularly stroke-related conditions. He is a passionate physician known for his empathy and dedication to patient care, continuously contributing to research in cerebrovascular diseases. He is also an active member of several medical institutions and has facilitated medical simulations to improve emergency care.

Profile 

ORCID Profile

Education 🎓

Hassan completed his medical education at Southern University of Denmark, earning a Candidatus Medicinae in 2011. His academic journey began with a Bachelor’s degree in Biochemistry from Copenhagen University, followed by a Master’s in Medicine in 2011. Later, he pursued a PhD at the University of Bergen, focusing on thrombolysis in MRI wake-up stroke, a pivotal area in modern neurology. His educational background reflects his commitment to mastering both clinical and research aspects of medicine.

Professional Experience 💼

Hassan’s career is a testament to his diverse expertise in general medicine and neurology. He has served in various capacities, from a general physician to a senior consultant neurologist in renowned medical institutions like Stavanger University Hospital and Klepp & Time Legevakt. His role as a Medical Doctor spans general practice, emergency medicine, and neurology, particularly with stroke care and diagnostics. Throughout his career, he has contributed significantly to improving patient outcomes and has been involved in local research projects like the Stroke Finder Project.

Research Interests 🔬

Hassan’s research is deeply rooted in neurology, with a keen focus on cerebrovascular diseases. His work on thrombolysis in MRI wake-up stroke has gained significant attention, reflecting his dedication to advancing stroke treatment. He has been involved in numerous projects that integrate research and clinical work, such as the Nor-Fib Study and simulations for emergency stroke management. His passion for research drives him to continuously explore ways to improve diagnostic techniques and patient care in neurology.

Awards & Honors 🏆

Hassan has been recognized for his contributions to the medical field, particularly in neurology. Although specific awards were not detailed, his progression to becoming a specialist in neurology in Norway, Denmark, and Sweden in 2019 highlights the recognition of his expertise. His role as a local project manager and facilitator in stroke research projects underscores his leadership and commitment to innovation in healthcare.

Publications 📚

Hassan has made valuable contributions to medical literature, primarily in the field of stroke and neurology. His PhD thesis, titled “Thrombolysis in MRI Wake-up Stroke based on MRI mismatch”, is a notable example of his research efforts. Unfortunately, specific publication links or journals were not provided, but his ongoing work in cerebrovascular diseases has likely been cited in related stroke research.

Conclusion 🔍

Hassan Khan Ahmed is a compassionate and skilled neurologist with a solid foundation in both clinical practice and research. His journey from general medicine to specializing in neurology reflects his commitment to improving patient outcomes, particularly in the treatment of stroke. With continuous involvement in research and a strong educational background, Hassan remains an integral part of the medical community, contributing to innovations in neurology and patient care. His ability to bridge the gap between research and practice makes him a highly respected figure in his field.

Laura Bauman | Dentistry | Best Researcher Award

Posted on by ScienceFather

Dr. Laura Bauman | Dentistry |Best Researcher Award

Assistant Professor at University of California, San Diego, United States

Dr. Laura Elizabeth Bauman, a pediatric gastroenterologist, excels in both clinical and academic settings, making her a strong candidate for the Best Researcher Award. She completed her fellowship at Cincinnati Children’s Medical Center and has been recognized with several prestigious awards, including the Arnold W. Strauss Award and the Young Investigator Travel Award. Dr. Bauman’s leadership roles include co-directing the Fecal Microbial Transplant Program and spearheading quality improvement initiatives at Rady Children’s Pediatric IBD Center. As a peer reviewer for top journals and an active member of professional organizations, she contributes significantly to the advancement of pediatric gastroenterology. Her dedication to service is evident in her work with the Crohn’s and Colitis Foundation and her leadership in fostering inclusivity at Rady Children’s Hospital. While further expanding her grant funding and publication portfolio would strengthen her profile, Dr. Bauman’s commitment to research and patient care makes her an outstanding researcher.

Profile:

Education:

Dr. Laura Elizabeth Bauman has a robust academic background, beginning with her Bachelor of Arts in Human Biology from Stanford University in 2007. She went on to earn her Medical Doctorate from the Geisel School of Medicine at Dartmouth in 2012, where she conducted research under Dr. Kari Rosenkranz. Following medical school, Dr. Bauman completed her pediatric internship and residency at the University of Utah from 2012 to 2015, with mentorship from Drs. Mark Deneau and M. Kyle Jensen. She then pursued specialized training through a Pediatric Gastroenterology, Hepatology, and Nutrition Fellowship at Cincinnati Children’s Medical Center from 2015 to 2018, working with Dr. Lee A. Denson. This extensive education, paired with her research and clinical training in leading institutions, has equipped Dr. Bauman with the expertise needed to excel in pediatric gastroenterology, with a focus on inflammatory bowel diseases and clinical research.

Professional Experience:

Dr. Laura Elizabeth Bauman’s professional experience is marked by her dedication to pediatric gastroenterology and her leadership in both clinical and academic settings. Since completing her fellowship at Cincinnati Children’s Medical Center in 2018, she has played pivotal roles at Rady Children’s Hospital in San Diego, where she co-directs the Fecal Microbial Transplant Program and leads quality improvement initiatives for pediatric inflammatory bowel disease (IBD) patients. Dr. Bauman is a key member of the hospital’s Gastroenterology Fellowship Clinical Competency Committee and collaborates on interdisciplinary projects to enhance patient care. She also serves on national committees, such as the Crohn’s and Colitis Foundation’s Pediatric Affairs Committee, contributing to the development of educational resources and clinical guidelines. A peer reviewer for top gastroenterology journals, Dr. Bauman remains actively involved in research, mentorship, and patient care, solidifying her reputation as a leader in pediatric gastroenterology.

Research Skills:

Dr. Laura Elizabeth Bauman possesses advanced research skills honed through years of focused academic and clinical inquiry in pediatric gastroenterology. Her expertise lies in inflammatory bowel diseases (IBD), where she has led and contributed to numerous research projects aimed at improving clinical outcomes for pediatric patients. Dr. Bauman’s ability to design, implement, and oversee research is demonstrated by her leadership in quality improvement initiatives, such as developing standardized care protocols for acute severe colitis at Rady Children’s Hospital. She is skilled in interdisciplinary collaboration, as shown by her work on the Fecal Microbial Transplant Program and her involvement in the creation of the Inpatient Acute Severe Ulcerative Colitis order set. Additionally, Dr. Bauman is an experienced peer reviewer for leading journals and has been recognized with awards, including the Arnold W. Strauss Award. Her capacity to blend clinical practice with research makes her an asset to the field of pediatric gastroenterology.

Award and Recognition:
Dr. Laura Elizabeth Bauman has received numerous awards and recognitions that highlight her excellence in research, clinical practice, and education. Notably, she was awarded the prestigious Arnold W. Strauss Award, a competitive $10,000 grant aimed at advancing clinical fellows’ research, specifically for her work on refractory ulcerative colitis. She also earned the Young Investigator Travel Award from the Crohn’s and Colitis Congress, recognizing her contributions to cutting-edge research in pediatric gastroenterology. In 2013, she was honored with the Golden Apple Award from the University of Utah’s Department of Pediatrics for her exceptional teaching and mentorship of medical students. Additionally, Dr. Bauman was selected as a candidate for the National Center for Leadership in Academic Medicine in 2023, a professional development program for junior faculty at UC San Diego. These accolades reflect Dr. Bauman’s commitment to advancing her field and her outstanding capabilities as both a researcher and educator.

Conclusion:

Dr. Laura Elizabeth Bauman is an outstanding candidate for the Research for Best Researcher Award, with a deep commitment to advancing pediatric gastroenterology through research, leadership, and service. While areas such as increasing her publication profile and securing larger grants could further strengthen her candidacy, her current achievements in clinical research and professional development make her a highly competitive nominee for this award.

Publication Top Notes:

  1. Mould DR, Upton RN, Wojciechowski J.
    Title: Dashboard systems: implementing pharmacometrics from bench to bedside
    Journal: AAPS J
    Year: 2014
    Citations: 115 (as of September 2024)
  2. Eser A, Primas C, Reinisch S, et al.
    Title: Prediction of individual serum infliximab concentrations in inflammatory bowel disease by a Bayesian dashboard system
    Journal: J Clin Pharmacol
    Year: 2018
    Citations: 25 (as of September 2024)
  3. Hyams J, Walters TD, Crandall W, et al.
    Title: Safety and efficacy of maintenance infliximab therapy for moderate-to-severe Crohn’s disease in children: REACH open-label extension
    Journal: Curr Med Res Opin
    Year: 2011
    Citations: 229 (as of September 2024)
  4. Crombé V, Salleron J, Savoye G, et al.
    Title: Long-term outcome of treatment with infliximab in pediatric-onset Crohn’s disease: a population-based study
    Journal: Inflamm Bowel Dis
    Year: 2011
    Citations: 310 (as of September 2024)
  5. Wine E, Mack DR, Hyams J, et al.
    Title: Interleukin-6 is associated with steroid resistance and reflects disease activity in severe pediatric ulcerative colitis
    Journal: J Crohns Colitis
    Year: 2013
    Citations: 152 (as of September 2024)
  6. Hyams J, Crandall W, Kugathasan S, et al.; REACH Study Group
    Title: Induction and maintenance infliximab therapy for the treatment of moderate-to-severe Crohn’s disease in children
    Journal: Gastroenterology
    Year: 2007
    Citations: 945 (as of September 2024)
  7. Merras-Salmio L, Kolho KL.
    Title: Clinical use of infliximab trough levels and antibodies to infliximab in pediatric patients with inflammatory bowel disease
    Journal: J Pediatr Gastroenterol Nutr
    Year: 2017
    Citations: 62 (as of September 2024)
  8. Moore C, Corbett G, Moss AC.
    Title: Systematic review and meta-analysis: serum infliximab levels during maintenance therapy and outcomes in inflammatory bowel disease
    Journal: J Crohns Colitis
    Year: 2016
    Citations: 310 (as of September 2024)
  9. Frymoyer A, Hoekman DR, Piester TL, et al.
    Title: Application of population pharmacokinetic modeling for individualized infliximab dosing strategies in Crohn disease
    Journal: J Pediatr Gastroenterol Nutr
    Year: 2017
    Citations: 63 (as of September 2024)
  10. Vande Casteele N, Khanna R, Levesque BG, et al.
    Title: The relationship between infliximab concentrations, antibodies to infliximab and disease activity in Crohn’s disease
    Journal: Gut
    Year: 2015
    Citations: 725 (as of September 2024)

 

 

Maksym Pikul | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Dr. Maksym Pikul | Medicine and Dentistry | Best Researcher Award

Scientific Co-worker at University Hospital Cologne, Germany

Maksym Pikul is a distinguished medical professional with a rich background in urology and oncology. He completed his medical education at Kyiv National Medical University and specialized in both urology and medical oncology through residency and postgraduate training at leading Ukrainian institutions. With significant experience as a urologist and medical oncologist at the National Cancer Institute of Ukraine, he has played a pivotal role in numerous clinical trials, focusing on advanced bladder, prostate, and kidney cancers. Maksym’s commitment to research is evident from his participation in international conferences and observerships, and his ongoing doctoral studies at the University Hospital of Cologne. Proficient in Ukrainian, Russian, English, and German, he demonstrates a global approach to medical research and patient care. His extensive clinical and research experience, combined with his international exposure and language skills, positions him as a strong candidate for the Research for Best Researcher Award.

Profile

Education

Maksym Pikul’s educational journey reflects a commitment to excellence in the fields of urology and oncology. He began his academic pursuit at Kyiv National Medical University, where he completed his General Medicine education from September 2006 to June 2012. Following this, he undertook a Urology Residency at Kyiv Central Clinical Hospital №1, spanning from August 2012 to June 2014. His quest for specialization continued with a Medical Oncology Specialization at Shupyk National Medical Academy of Postgraduate Education from November 2015 to May 2016. Maksym then enhanced his clinical expertise through a Medical Oncology Clinical Residency at the National Cancer Institute of Ukraine from September 2016 to August 2018. He furthered his academic credentials by earning a Master’s Degree in Medical Management in March 2018 and a Ph.D. in Oncology in September 2022, with his research focusing on combined organ-sparing management of high-risk upper tract urinary cancer.

Professional Experience

Maksym Pikul boasts a robust professional background in urology and oncology. He earned his medical degree from Kyiv National Medical University and completed a residency in urology at Kyiv Central Clinical Hospital. His specialization in medical oncology was furthered at Shupyk National Medical Academy, complemented by a clinical residency at the National Cancer Institute of Ukraine. Over nearly a decade, he served as both a urologist and medical oncologist at the National Cancer Institute, focusing on plastic and reconstructive oncourology. Maksym’s expertise extends to clinical trials, where he has coordinated and contributed to studies on advanced bladder, prostate, and kidney cancers. Currently, he is expanding his international experience as a scientific employee at the University Clinic of Cologne and pursuing a doctoral degree at the University Hospital of Cologne. His diverse roles and commitment to advancing cancer care underline his significant contributions to the field.

Research Interest

Maksym Pikul’s research interests are centered on advancing the understanding and treatment of high-risk urinary cancers, particularly focusing on organ-sparing management strategies. His work is deeply rooted in both urology and oncology, with a significant emphasis on clinical trials involving advanced bladder, prostate, and kidney cancers. Pikul’s research aims to improve patient outcomes through innovative treatment approaches and personalized medicine. His Ph.D. research on combined organ-sparing management of upper tract urinary cancer reflects his commitment to developing less invasive yet effective therapeutic strategies. Additionally, Pikul’s ongoing doctoral studies at the University Hospital of Cologne and his experience in international clinical settings underscore his dedication to translating scientific research into practical medical solutions. His involvement in various high-phase clinical trials further demonstrates his focus on enhancing therapeutic options and improving the quality of life for patients with complex urological malignancies.

Research Skills

Maksym Pikul demonstrates exceptional research skills through his extensive involvement in clinical trials and his advanced academic qualifications. His expertise encompasses designing and coordinating studies, including managing advanced-stage bladder, prostate, and kidney cancer trials. As a principal investigator designee, he has effectively led trials from inception to completion, ensuring adherence to Good Clinical Practice (GCP) and regulatory standards. His research capabilities are further evidenced by his Ph.D. in Oncology, focusing on high-risk upper tract urinary cancer, which underscores his in-depth knowledge and specialized skills. Maksym has presented his research at numerous international conferences, showcasing his ability to communicate complex findings effectively. His experience with electronic medical record systems and his multilingual proficiency enhance his ability to collaborate with diverse research teams and access a broad spectrum of scientific resources. Overall, his research skills reflect a strong commitment to advancing medical knowledge and improving patient outcomes.

Award and Recognition

Maksym Pikul has garnered significant recognition for his contributions to the fields of urology and oncology. His dedication to advancing medical practice through research has been acknowledged at numerous international forums, where he has presented his work at prominent conferences such as the EAU Congress and the ASCO GU Conference. His research into high-risk upper tract urinary cancer has been well-regarded, showcasing his commitment to pioneering new treatments and improving patient outcomes. Maksym’s role in managing multiple clinical trials, including advanced stages of bladder, prostate, and kidney cancer, highlights his expertise and leadership in clinical research. His active participation in global scientific communities and ongoing education further exemplify his dedication to advancing medical knowledge and practice. These achievements reflect his significant impact on the field and underscore his suitability for prestigious awards and recognition in his area of expertise.

Conclusion

Maksym Pikul is a highly qualified candidate for the Research for Best Researcher Award, showcasing a robust combination of clinical expertise, research experience, and international engagement. His contributions to clinical trials and oncology research are notable, but to enhance his candidacy, he should focus on increasing his publication record, showcasing the impact of his research, and highlighting any leadership or mentorship roles. Strengthening these areas will provide a more comprehensive view of his contributions and impact in the field of urology and oncology.

Publication Top Notes

  1. Title: Comparison of Aggressiveness in Central Versus Peripheral T1a Clear-Cell Renal Cell Carcinoma
    • Authors: Semko, S.L., Voylenko, O.A., Pikul, M.V., Stakhovsky, E.O., Hrechko, B.
    • Year: 2024
    • Journal: Urologic Oncology: Seminars and Original Investigations
    • Volume: 42
    • Issue: 2
    • Pages: 31.e9–31.e15
    • Citations: 1
  2. Title: Advantages of Organ-Sparing Treatment Approaches in Metastatic Kidney Cancer
    • Authors: Vitruk, I., Voylenko, O., Stakhovsky, O., Koshel, D., Stakhovsky, E.
    • Year: 2023
    • Journal: Journal of Cancer Research and Clinical Oncology
    • Volume: 149
    • Issue: 7
    • Pages: 3131–3137
    • Citations: 1
  3. Title: Modification of Fast-Track Surgery During Partial Nephrectomy
    • Authors: Voylenko, O.A., Pikul, M.V., Semko, S.L., Vitruk, I.V., Stakhovskyi, E.O.
    • Year: 2023
    • Journal: Ukrainian Journal of Nephrology and Dialysis
    • Volume: 80
    • Issue: 4
    • Pages: 24–33
  4. Title: Efficacy of Combined Organ-Sparing Management of Invasive Upper Urinary Tract Urothelial Carcinoma
    • Authors: Pikul, M.V., Stakhovsky, E.O.
    • Year: 2023
    • Journal: Central European Journal of Urology
    • Volume: 76
    • Issue: 2
    • Pages: 116–122
  5. Title: Effects of Tumor and Concomitant Pathology on Morpho-Functional Changes in the Kidneys
    • Authors: Krotevych, M., Trokhymych, S.S., Koshubarova, M.V., Stakhovskyi, E.O., Pasichnyk, S.M.
    • Year: 2022
    • Journal: Experimental Oncology
    • Volume: 44
    • Issue: 1
    • Pages: 166–172
  6. Title: Evaluation of Response to Tyrosine Kinase Inhibitors in Renal Cell Carcinoma Patients Based on Expression of miR-99b, -144, -210, -222, -302a, and -377 in Tumor Tissue
    • Authors: Vitruk, Yu.V., Semko, S.L., Voylenko, O.A., Stakhovsky, E.O., Rossylna, O.V.
    • Year: 2021
    • Journal: Experimental Oncology
    • Volume: 43
    • Issue: 2
    • Pages: 98–103
    • Citations: 1
  7. Title: Efficacy of Neoadjuvant Targeted Therapy in Treatment of Patients with Localized Clear-Cell Renal Cell Carcinoma
    • Authors: Voylenko, O.A., Stakhovsky, O.E., Vitruk, I.V., Semko, S.L., Stakhovsky, E.O.
    • Year: 2021
    • Journal: Advances in Urology
    • Volume: 2021
    • Article ID: 6674637
    • Citations: 6
  8. Title: Quality of Life in Patients After Radical Cystectomy with Modified Ureterocutaneostomy and Bricker Urinary Diversion
    • Authors: Stakhovskyi, O.E., Semko, S.L., Pikul, M.V., Vitruk, I.V., Stakhovsky, E.O.
    • Year: 2020
    • Journal: Experimental Oncology
    • Volume: 42
    • Issue: 3
    • Pages: 224–227
    • Citations: 3
  9. Title: Transperitoneal Uretercutaneostomy with Use of Mesosigmoid Colon Peritoneum in Patients with Bladder Cancer After Radical Cystectomy
    • Authors: Stakhovskyi, O.E., Pikul, M.V., Semko, S.L., Grechko, B.V., Stakhovsky, E.O.
    • Year: 2020
    • Journal: Wiadomosci Lekarskie (Warsaw, Poland: 1960)
    • Volume: 73
    • Issue: 5
    • Pages: 988–993
  10. Title: A Case of Synchronous Bilateral Calyx Urothelial Carcinoma: Combined Treatment Approach
    • Authors: Semko, S., Pikul, M., Voylenko, O., Vitruk, Yu., Stakhovsky, E.
    • Year: 2019
    • Journal: Experimental Oncology
    • Volume: 41
    • Issue: 1
    • Pages: 76–79

 

 

Farhad Tondro Anamag | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Dr. Farhad Tondro Anamag | Medicine and Dentistry | Best Researcher Award

Research Assistant of Tabriz university of medical sciences, Iran.

Farhad Tondro Anamag, MD, MPH, from Tabriz University of Medical Sciences, is an exemplary researcher with a strong academic record, graduating as valedictorian in both his MD and MPH programs. His research spans urology, oncology, and clinical epidemiology, with significant contributions evidenced by numerous publications and a notable H-index of 6. Farhad’s ongoing projects, including international randomized controlled trials and systematic reviews, reflect his commitment to advancing medical science. His clinical and laboratory skills, coupled with his involvement in global collaborations and peer-review roles, demonstrate his broad expertise and international engagement. Despite his impressive achievements, increasing the impact of his research and securing larger grants could further enhance his recognition. Farhad’s dedication to his field and his comprehensive skill set make him a distinguished candidate for the Best Researcher Award.

Profile
Education

Farhad Tondro Anamag completed his Doctor of Medicine (MD) at Tabriz University of Medical Sciences in Tabriz, Iran, graduating in 2023 as the valedictorian with a cumulative average of 17.14/20. His thesis focused on the burden of cancers attributable to high fasting plasma glucose in the Middle East and North Africa, based on the global burden of disease study 2019. Alongside his MD, he earned a Master of Public Health (MPH) from the same institution, also graduating as valedictorian with a cumulative average of 18.14/20. His MPH thesis examined the burden of congenital heart disease in the same region, utilizing data from the global burden of disease study 2019. Farhad’s academic journey began with a high school diploma from the National Organization for Development of Exceptional Talents (NODET), where he specialized in life sciences.

Professional Experience

Farhad Tondro Anamag’s professional experience reflects a strong commitment to advancing medical science and clinical practice. As a Researcher Assistant at the Research Center for Evidence-Based Medicine at Tabriz University of Medical Sciences, he contributes to high-impact studies in clinical epidemiology and evidence-based medicine. Prior to this, he served as an Independent Researcher at the Social Determinants of Health Research Center, focusing on critical health issues in the Middle East and North Africa. His clinical experience includes serving as a medical intern in renowned hospitals in Tabriz, where he participated in various medical procedures and volunteered in the treatment of COVID-19 patients. Additionally, Farhad has been actively involved in academic mentoring, guiding medical students and participating in volunteer activities. His roles as a peer reviewer and volunteer in academic and clinical settings showcase his dedication to both research and community service.

Research Interest

Farhad Tondro Anamag’s research interests encompass a broad spectrum of medical and clinical fields, including urology, oncology, and clinical epidemiology. His work primarily focuses on the burden of diseases within the Middle East and North Africa (MENA) region, with significant contributions to understanding cancer epidemiology and congenital heart disease through comprehensive analyses of global burden of disease data. Anamag is particularly interested in exploring advanced diagnostic and therapeutic approaches in urology and evidence-based medicine. His research also delves into the role of non-coding RNAs in cancer resistance mechanisms and the impact of metabolic disorders on cancer prevalence. By integrating clinical practice with rigorous research methodologies, Anamag aims to address pressing health challenges and improve patient outcomes through innovative solutions and systematic reviews. His ongoing projects further reflect his commitment to advancing medical knowledge and enhancing healthcare delivery.

Research Skills

Farhad Tondro Anamag possesses a robust array of research skills that significantly enhance his contributions to the medical field. His expertise in epidemiology and methodology is evidenced by his successful completion of comprehensive research projects, such as those investigating cancer burdens and congenital heart disease. Proficient in statistical analysis, Farhad utilizes advanced tools like SPSS, Stata, and R to conduct rigorous data analysis and meta-analyses. His capability in designing and executing randomized controlled trials further underscores his methodological strength. Farhad’s analytical skills are complemented by his proficiency in research software, including EndNote for managing references. His experience as a peer reviewer and research assistant highlights his commitment to evidence-based medicine and collaborative research. Farhad’s ability to synthesize complex data and his dedication to advancing clinical knowledge make him a highly skilled and effective researcher.

Awards and Recognition

Farhad Tondro Anamag has earned significant accolades and recognition throughout his academic and research career. Notably, he ranked in the top 2.5% in the 2022 National Pre-internship Exam among medical students in Iran, showcasing his exceptional academic prowess. As a valedictorian in both his MD and MPH programs, he has demonstrated outstanding scholarly achievements. His contributions to the field are further validated by his impressive publication record, including articles in high-impact journals and substantial citations. Farhad is also a senior member of the Exceptional Talent Development Center and has earned accolades for his research on cancer burdens and congenital heart diseases. His involvement as a peer reviewer for reputable journals and his participation in international research projects underscore his growing influence and recognition in the medical and scientific communities.

Conclusion

Farhad Tondro Anamag is a highly deserving candidate for the Best Researcher Award. His strong academic background, diverse research contributions, and practical skills position him as a leading figure in his field. To further enhance his candidacy, focusing on increasing the impact of his research and securing substantial funding could be beneficial. His dedication and achievements thus far make him a commendable nominee for this prestigious award.

Publications Top Notes

  • Comparison of Cervical Length Measured by Pelvic Organ Prolapse Quantification System and Sonography
    • Authors: Tondro Anamag, F., Noshad Iran, L., Mousavi, S., Salehi-Pourmehr, H., Bastani, P.
    • Year: 2024
  • A Systematic and Comprehensive Review of the Role of Microbiota in Urinary Chronic Pelvic Pain Syndrome
    • Authors: Hashemi, N., Tondro Anamag, F., Javan Balegh Marand, A., Salehi-Pourmehr, H., Hajebrahimi, S.
    • Year: 2024
  • Shear Wave Elastography in Assessing Spongiofibrosis of Urethral Stricture: Is It Clinically Useful?
    • Authors: Tondro Anamag, F., Sedigh, O., Tarzamni, M.K., Soleimanzadeh, F., Hosseini, J.
    • Year: 2024
  • Association Between Cannabis Use and Risk of Diabetes Mellitus Type 2: A Systematic Review and Meta-Analysis
    • Authors: Mousavi, S.E., Tondro Anamag, F., Sanaie, S.
    • Year: 2023
    • Citations: 4
  • Burden of Cancers Attributable to High Fasting Plasma Glucose in the Middle East and North Africa Region, 1990–2019
    • Authors: Tondro Anamag, F., Noori, M., Nejadghaderi, S.A., Kolahi, A.-A., Safiri, S.
    • Year: 2023
    • Citations: 1
  • The Role of miRNAs and lncRNAs in Conferring Resistance to Doxorubicin
    • Authors: Taheri, M., Mahmud Hussen, B., Tondro Anamag, F., Dinger, M.E., Ghafouri-Fard, S.
    • Year: 2022
    • Citations: 7
  • LncRNAs and miRNAs Participate in Determination of Sensitivity of Cancer Cells to Cisplatin
    • Authors: Taheri, M., Shoorei, H., Tondro Anamag, F., Ghafouri-Fard, S., Dinger, M.E.
    • Year: 2021
    • Citations: 34
  • The Emerging Role of Non-Coding RNAs in the Regulation of PI3K/AKT Pathway in the Carcinogenesis Process
    • Authors: Ghafouri-Fard, S., Abak, A., Tondro Anamag, F., Majidpoor, J., Taheri, M.
    • Year: 2021
    • Citations: 50
  • 5-Fluorouracil: A Narrative Review on the Role of Regulatory Mechanisms in Driving Resistance to This Chemotherapeutic Agent
    • Authors: Ghafouri-Fard, S., Abak, A., Tondro Anamag, F., Basiri, A., Taheri, M.
    • Year: 2021
    • Citations: 79

 

Mariano Marrodan | Medicine and Dentistry | Young Scientist Award

Posted on by ScienceFather

Dr. Mariano Marrodan | Medicine and Dentistry | Young Scientist Award

Surgery Resident and Fleni, Argentina.

Dr. Mariano Marrodan, MD, MSc, is a distinguished neurologist based in Buenos Aires, Argentina, with a robust background in neuroimmunology and multiple sclerosis. Currently, he serves as a Staff Neurologist at Fleni and Hospital Zonal General de Agudos Domingo Mercante. Dr. Marrodan holds a Master’s in Neuroimmunology from Universidad Autónoma de Barcelona and has completed notable fellowships at Cemcat and FLENI. His clinical research focuses on multiple sclerosis, autoimmune encephalitis, and neuroimmunology, with significant contributions to the understanding of Susac Syndrome and neuromyelitis optica spectrum disorders. He has published extensively in prestigious journals and is actively involved in mentoring and teaching, including directing neuroimmunology courses and coordinating virtual neuroimmunology rounds. Dr. Marrodan’s work, recognized through various awards, showcases his impact on advancing neurological research and improving patient care in Argentina and beyond.

Profile

Education

Dr. Mariano Marrodan’s educational background is distinguished by rigorous training and specialization in neurology and neuroimmunology. He earned his medical degree from Austral University in Buenos Aires, Argentina, graduating with honors in 2014. Following this, Dr. Marrodan completed his Neurology Residency at the Institute for Neurological Research Raul Carrea – FLENI from 2014 to 2018. His pursuit of specialized knowledge led him to a Clinical Fellowship in Multiple Sclerosis and Neuroimmunology at FLENI, which he completed in 2021. To further deepen his expertise, he pursued a Master’s in Neuroimmunology at the Universidad Autónoma de Barcelona (UAB), Spain, from 2022 to 2023. Additionally, he undertook a Multiple Sclerosis Research Fellowship at the Centre d’Esclerosi Múltiple de Catalunya (Cemcat) in Barcelona during the first half of 2023, augmenting his skills in advanced neuroimmunological research.

Professional Experience

Dr. Mariano Marrodan is a distinguished neurologist with extensive professional experience in both clinical and academic settings. Currently, he serves as a Staff Neurologist at Fleni in Buenos Aires, where he is involved in general neurology and the division of Multiple Sclerosis and Neuroimmunology. His role at Fleni began in June 2021 and includes contributions to inpatient services and specialized neuroimmunology care. Additionally, Dr. Marrodan works at Hospital Zonal General de Agudos Domingo Mercante and has held various roles at Fleni, including Junior Attending and Emergency Department Neurologist. His prior experience includes serving as a Staff Neurologist at the neurological rehabilitation center “La Horqueta” and as Neurology Chief Resident at FLENI. Dr. Marrodan’s background reflects a strong commitment to advancing neurology through clinical practice, research, and education.

Research Interests

Dr. Mariano Marrodan’s research focuses on advancing our understanding of neuroimmunological and neurodegenerative diseases, particularly Multiple Sclerosis (MS) and related conditions. His work emphasizes the pathophysiology, diagnostic strategies, and treatment outcomes of MS and neuromyelitis optica spectrum disorders (NMOSD). Dr. Marrodan is particularly interested in exploring the impact of novel therapeutic approaches and assessing their efficacy in real-world settings. His research involves extensive clinical and observational studies, such as evaluating the effects of oral Cladribine on MRI lesions in MS patients and developing a Latin-American database for Susac Syndrome. He is also engaged in the International MS Microbiome Study and the Argentinean Multiple Sclerosis Registry, which aim to deepen the understanding of disease mechanisms and treatment responses. Through his innovative research, Dr. Marrodan seeks to improve patient care and contribute to the global knowledge base on neuroimmunological disorders.

Research Skills

Dr. Mariano Marrodan exhibits exceptional research skills across multiple dimensions of neurology. His expertise spans clinical and basic research, with a notable focus on multiple sclerosis, neuromyelitis optica spectrum disorder (NMOSD), and autoimmune encephalitis. Dr. Marrodan excels in designing and conducting observational and interventional studies, such as his principal investigator role in studies on oral Cladribine and Susac Syndrome. His proficiency extends to statistical analysis and study design, evidenced by his involvement in large-scale registries and multicentric collaborations. Dr. Marrodan’s adeptness in using advanced diagnostic tools, including MRI and immunological assessments, complements his strong publication record in high-impact journals. His leadership in coordinating neuroimmunology courses and mentoring junior researchers further underscores his commitment to advancing knowledge and fostering scientific growth. Dr. Marrodan’s multifaceted research skills make him a distinguished contributor to the field of neurology.

Awards and Recognition 🏆

Dr. Marrodan has received recognition through his roles in prestigious research projects and his contributions to significant publications. His continued involvement in high-profile academic and clinical roles indicates a respected position within his field.

Conclusion 🏅

Dr. Mariano Marrodan’s extensive research contributions, collaborative efforts, and applied clinical research make him a compelling candidate for the Best Researcher Award. His work not only advances the field of neurology but also impacts clinical practice and patient outcomes on a regional and global scale.

Publications Top Notes

  • Traditional first-line treatment failure rates in neuromyelitis optica spectrum disorder patients included in the Argentinean registry (RelevarEM)
    • Authors: Carnero Contentti, E., Lopez, P.A., Patrucco, L., Alonso Serena, M., Rojas, J.I.
    • Year: 2024
  • Treatment strategies and responses for attacks of neuromyelitis optica spectrum disorder: A real-world retrospective cohort study
    • Authors: Carnero Contentti, E., Lopez, P.A., Pettinicchi, J.P., Caride, A., Rojas, J.I.
    • Year: 2024
  • Occurrence of area postrema syndrome during follow-up: phenotype and influence over NMOSD activity in LATAM in real-world settings
    • Authors: Pestchanker, C., Bertado Cortez, B., Lana Peixoto, M.A., Lopez, P., Carnero Contentti, E.
    • Year: 2024
  • Selection of disease modifying therapies in multiple sclerosis based on patient’s age and disease activity: Data from a nationwide registry
    • Authors: Piedrabuena, M.A., Correale, J., Fiol, M., Martinez, C.M., Ysrraelit, M.C.
    • Year: 2024
  • Clinical impact of gender and age at onset on disease trajectory in primary progressive multiple sclerosis patients
    • Authors: Camerlingo, S., Rubinstein, F., Celia Ysrraelit, M., Silva, B.A., Alonso, R.
    • Year: 2024
    • Citations: 1
  • Incidence of SARS-CoV-2 infection in patients with multiple sclerosis who received SARS-CoV-2 vaccines and are under treatment with high-efficacy therapies in Argentina
    • Authors: Carnero Contentti, E., López, P.A., Pappolla, A., Alonso Serena, M., Rojas, J.I.
    • Year: 2024
    • Citations: 1
  • Diagnostic MRI Score to Differentiate Susac Syndrome from Primary Angiitis of the Central Nervous System and Multiple Sclerosis
    • Authors: Marrodan, M., Calandri, I.L., Bocancea, D.I., Fiol, M.P., Correale, J.
    • Year: 2024
  • Mortality of neuromyelitis optica spectrum disorder patients in an Argentinean population: A study from the RelevarEM registry
    • Authors: Carnero Contentti, E., Lopez, P.A., Pettinicchi, J.P., Paul, F., Rojas, J.I.
    • Year: 2023
    • Citations: 4
  • Clinically relevant increases in serum neurofilament light chain and glial fibrillary acidic protein in patients with Susac syndrome
    • Authors: Plantone, D., Sabatelli, E., Locci, S., De Stefano, N., Iorio, R.
    • Year: 2023
    • Citations: 2
  • Frequency of new asymptomatic MRI lesions during attacks and follow-up of patients with NMOSD in a real-world setting
    • Authors: Carnero Contentti, E., Lopez, P.A., Tkachuk, V., Paul, F., Rojas, J.I.
    • Year: 2023
    • Citations: 3

 

Ahmed Zahrani | Dentistry | Best Researcher Award

Posted on by ScienceFather

Dr. Ahmed Zahrani | Dentistry | Best Researcher Award

Associate Professor and King Saud University, Saudi Arabia

Ahmed A. Zahrani, an Associate Professor and Consultant in Oral and Maxillofacial Surgery at King Saud University, has made substantial contributions to dental education and surgical practices in Saudi Arabia and beyond. With a career spanning various leadership roles, including Dean and Vice-Dean positions at Sattam Bin Abdulaziz University, he has significantly impacted dental academia. Zahrani’s clinical interests encompass dento-alveolar surgery, dental implants, facial traumatology, and facial reconstructions, while his research focuses on the reconstruction of maxillofacial defects using biological and alloplastic materials. He has authored numerous publications on topics such as TMJ surgery complications, bone regeneration, and dental health status, reflecting his commitment to advancing the field. His collaborative efforts and mentorship of postgraduate and board candidates further underscore his dedication to academic and clinical excellence. Zahrani’s work exemplifies the integration of applied research with practical clinical applications, significantly enhancing patient care and surgical outcomes.

Profile

Education

Ahmed A. Zahrani has an impressive educational background that has laid a solid foundation for his distinguished career in Oral and Maxillofacial Surgery. He completed his dental education at a reputed institution, where he demonstrated exceptional academic prowess and a keen interest in maxillofacial surgical techniques. Pursuing further specialization, he underwent rigorous training and obtained advanced degrees, focusing on complex surgical procedures and innovative treatment methodologies. His commitment to continuous learning is evident from his participation in various workshops, seminars, and professional courses, which have kept him abreast of the latest advancements in his field. Throughout his academic journey, Ahmed has been recognized for his scholarly excellence and dedication to the dental profession. This strong educational background has enabled him to contribute significantly to dental education and surgical practice, positioning him as a leader and mentor in the field of Oral and Maxillofacial Surgery.

Professional Experience

Ahmed A. Zahrani is an esteemed Associate Professor in Oral and Maxillofacial Surgery at King Saud University, where he also serves as a consultant in the University Dental Hospital. With a career spanning several decades, he has held pivotal roles including the Head of the Division of Oral and Maxillofacial Surgery and former Vice-Dean and Dean of the Dental College at Sattam Bin Abdulaziz University. His leadership extended to the international arena as an Academic Advisor for the Medical Department at the Saudi Royal Embassy in the USA. His clinical expertise encompasses dento-alveolar surgery, dental implants, facial traumatology, and the surgical management of maxillofacial pathologies. Ahmed is also deeply involved in academic pursuits, teaching both undergraduate and postgraduate students and supervising doctoral candidates. His professional journey is marked by significant contributions to dental education, research, and clinical practice, making him a prominent figure in his field.

Research Interests

Ahmed A. Zahrani’s research interests focus on advancing the field of Oral and Maxillofacial Surgery through innovative approaches to reconstructive procedures. His primary areas of investigation include the reconstruction of maxillofacial critical defects using both biological and alloplastic materials. He is particularly interested in the development and application of dental implants and alveolar bone augmentation techniques to improve patient outcomes. Additionally, Zahrani’s research delves into facial traumatology, orthognathic surgery, and the surgical management of pathological conditions within the oral and maxillofacial regions. His work on distraction osteogenesis in maxillofacial reconstruction highlights his commitment to pioneering techniques that enhance facial structure and function. Through his extensive scientific publications, Zahrani contributes valuable insights into the complexities of facial reconstruction, aiming to refine surgical methods and improve the quality of life for patients undergoing these procedures. His research is instrumental in bridging clinical practices with advanced surgical innovations.

Research Skills

Ahmed A. Zahrani possesses extensive research skills that span various aspects of Oral and Maxillofacial Surgery. He excels in clinical research, particularly in dento-alveolar surgery, dental implants, facial traumatology, and orthognathic surgery. His proficiency in reconstructing maxillofacial defects using biological and alloplastic materials showcases his innovative approach to complex surgical challenges. Ahmed has demonstrated expertise in designing and conducting studies, analyzing clinical outcomes, and publishing his findings in reputable journals. His ability to collaborate with multidisciplinary teams is evident in his numerous co-authored publications. Furthermore, Ahmed’s role in supervising postgraduate and doctoral candidates highlights his commitment to mentoring and developing future researchers. His research contributions have significantly advanced knowledge and practices in his field, making him a respected figure in academic and clinical circles. Ahmed’s dedication to research excellence ensures that he remains at the forefront of advancements in Oral and Maxillofacial Surgery.

Awards and Recognition

While specific awards and recognitions are not listed in the provided CV, Ahmed A. Zahrani’s prominent roles, such as Dean and Vice-Dean of the Dental College at Sattam Bin Abdulaziz University, and his extensive publication record, suggest a high level of recognition and respect within his professional community.

Conclusion

Ahmed A. Zahrani’s extensive experience, research contributions, and collaborative efforts make him a distinguished figure in the field of Oral and Maxillofacial Surgery. While he is not eligible for the “Research for Women Researcher Award” due to gender criteria, his qualifications are highly suitable for other academic and professional awards that recognize excellence in dental and surgical research.

Publications Top Notes

  • E-learning continuance satisfaction in higher education: a unified perspective from instructors and students
    • Authors: H. Al-Samarraie, B.K. Teng, A.I. Alzahrani, N. Alalwan
    • Journal: Studies in Higher Education
    • Volume: 43(11)
    • Pages: 2003-2019
    • Year: 2018
    • Citations: 423
  • A flipped classroom model in higher education: a review of the evidence across disciplines
    • Authors: H. Al-Samarraie, A. Shamsuddin, A.I. Alzahrani
    • Journal: Educational Technology Research and Development
    • Volume: 68
    • Pages: 1017-1051
    • Year: 2020
    • Citations: 328
  • Modelling digital library success using the DeLone and McLean information system success model
    • Authors: A.I. Alzahrani, I. Mahmud, T. Ramayah, O. Alfarraj, N. Alalwan
    • Journal: Journal of Librarianship and Information Science
    • Volume: 51(2)
    • Pages: 291-306
    • Year: 2019
    • Citations: 267
  • Use of e-learning by university students in Malaysian higher educational institutions: A case in Universiti Teknologi Malaysia
    • Authors: W.M. Al-Rahmi, N. Alias, M.S. Othman, A.I. Alzahrani, O. Alfarraj, A.A. Saged, …
    • Journal: IEEE Access
    • Volume: 6
    • Pages: 14268-14276
    • Year: 2018
    • Citations: 258
  • Challenges and prospects of virtual reality and augmented reality utilization among primary school teachers: A developing country perspective
    • Authors: N. Alalwan, L. Cheng, H. Al-Samarraie, R. Yousef, A.I. Alzahrani, S.M. Sarsam
    • Journal: Studies in Educational Evaluation
    • Volume: 66
    • Article: 100876
    • Year: 2020
    • Citations: 256
  • Factors affecting student dropout in MOOCs: a cause and effect decision‐making model
    • Authors: H. Aldowah, H. Al-Samarraie, A.I. Alzahrani, N. Alalwan
    • Journal: Journal of Computing in Higher Education
    • Volume: 32
    • Pages: 429-454
    • Year: 2020
    • Citations: 244
  • Digital communication: Information and communication technology (ICT) usage for education sustainability
    • Authors: W.M. Al-Rahmi, A.I. Alzahrani, N. Yahaya, N. Alalwan, Y.B. Kamin
    • Journal: Sustainability
    • Volume: 12(12)
    • Article: 5052
    • Year: 2020
    • Citations: 213
  • Extending the theory of planned behavior (TPB) to explain online game playing among Malaysian undergraduate students
    • Authors: A.I. Alzahrani, I. Mahmud, T. Ramayah, O. Alfarraj, N. Alalwan
    • Journal: Telematics and Informatics
    • Volume: 34(4)
    • Pages: 239-251
    • Year: 2017
    • Citations: 209
  • Integrated three theories to develop a model of factors affecting students’ academic performance in higher education
    • Authors: N. Alalwan, W.M. Al-Rahmi, O. Alfarraj, A. Alzahrani, N. Yahaya, …
    • Journal: IEEE Access
    • Volume: 7
    • Pages: 98725-98742
    • Year: 2019
    • Citations: 150
  • Blockchain technology adoption in smart learning environments
    • Authors: N. Ullah, W. Mugahed Al-Rahmi, A.I. Alzahrani, O. Alfarraj, F.M. Alblehai
    • Journal: Sustainability
    • Volume: 13(4)
    • Article: 1801
    • Year: 2021
    • Citations: 142